Product

Ketamine HCl

1 clinical trial

1 indication

Indication

Complex Regional Pain Syndromes

Clinical trial

A Phase 2 Single-arm, Open Label Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Ketamine HCl Prolonged Release Tablets in Participants With Complex Regional Pain Syndrome

Status: Not yet recruiting, Estimated PCD: 2026-01-01